Nuzenio

Artiva Biotherapeutics Reports

Artiva Biotherapeutics Reports news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Artiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41 - tipranks.comtipranks.com · Fri, 07 Aug 2026 10:59:49 GMTArtiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 00:12:00 GMTArtiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:05:00 GMTInsider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Acquires 20,824 Shares - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMTArtiva Biotherapeutics (NASDAQ:ARTV) Director Purchases $247,693.92 in Stock - MarketBeatMarketBeat · Fri, 31 Jul 2026 07:00:00 GMTRA Capital Management buys USD 456,297 of Artiva Biotherapeutics common shares - BitgetBitget · Fri, 31 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 10:59:49 GMTArtiva Therapeutics: Buy Rating Reiterated on Strong AlloNK RA Profile and Upcoming Phase III, Price Target Maintained at $41 - tipranks.com
Fri, 07 Aug 2026 00:12:00 GMTArtiva Biotherapeutics Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView
Thu, 06 Aug 2026 20:05:00 GMTArtiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewswire
Fri, 31 Jul 2026 07:00:00 GMTInsider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Acquires 20,824 Shares - MarketBeat
Fri, 31 Jul 2026 07:00:00 GMTArtiva Biotherapeutics (NASDAQ:ARTV) Director Purchases $247,693.92 in Stock - MarketBeat
Fri, 31 Jul 2026 07:00:00 GMTRA Capital Management buys USD 456,297 of Artiva Biotherapeutics common shares - Bitget

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Artiva Biotherapeutics Reports.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.